Compound Detail
CHEMBL451364
EREMANTHIN Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL451364 |
| Name | EREMANTHIN |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BWRZDLYJNURUHS-XUXIUFHCSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
230.3
MW (Da)
3.02
ALogP
2
HBA
0
HBD
26.3
PSA (Ų)
0.36
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.96
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 11000.0 | nM | 4.96 | Inhibition of killing activity of CD8+ specific mouse CTL-OE4 cells | 9917276 |
| A549 | IC50 | = | 46000.0 | nM | 4.34 | Inhibition of IL-1-beta-induced ICAM1 expression in human A549 cells | 9917276 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1007/s00044-010-9448-5 | Rattus norvegicus | 5 |
| 9917276 | 10.1021/np980092u | Unchecked | 1 |
| 9917276 | 10.1021/np980092u | A549 | 1 |
Data from ChEMBL 36 via Core Engine